Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer

NCT06903377 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

BIOLOGICAL: ZG005 for Injection
DRUG: Gecacitinib Hydrochloride Tablets

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd